Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-29

Clinical Trial Update: Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating tesamorelin as an adjunct to exercise to improve physical function in adults with HIV infection and frailty; the study is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tesamorelin (tesamorelin)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: HIV-1-infection, Frailty | Phase 2 | Status: RECRUITING